These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 18346229)

  • 1. Chemotherapy-induced neuropathy.
    Windebank AJ; Grisold W
    J Peripher Nerv Syst; 2008 Mar; 13(1):27-46. PubMed ID: 18346229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced peripheral neuropathy.
    Hilkens PH; ven den Bent MJ
    J Peripher Nerv Syst; 1997; 2(4):350-61. PubMed ID: 10975744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug induced neuropathies].
    Lagueny A
    Rev Prat; 2008 Nov; 58(17):1910-6. PubMed ID: 19157207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral neuropathy induced by microtubule-stabilizing agents.
    Lee JJ; Swain SM
    J Clin Oncol; 2006 Apr; 24(10):1633-42. PubMed ID: 16575015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy].
    Nakane M
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents.
    Argyriou AA; Zolota V; Kyriakopoulou O; Kalofonos HP
    J BUON; 2010; 15(3):435-46. PubMed ID: 20941808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
    Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
    Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
    Wickham R
    Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of efficacy and safety of adjuvant analgesics for peripheral neuropathy induced by cancer chemotherapy in digestive cancer patients-a pilot study].
    Yano T; Yamane H; Fukuoka R; Ninomiya T; Umemura S; Suzuki S; Saeki H; Hanaoka T; Katou T; Itoh K; Fujita T; Kamei H
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):83-7. PubMed ID: 19151568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth.
    Kirchmair R; Walter DH; Ii M; Rittig K; Tietz AB; Murayama T; Emanueli C; Silver M; Wecker A; Amant C; Schratzberger P; Yoon YS; Weber A; Panagiotou E; Rosen KM; Bahlmann FH; Adelman LS; Weinberg DH; Ropper AH; Isner JM; Losordo DW
    Circulation; 2005 May; 111(20):2662-70. PubMed ID: 15897348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma, painful neuropathy, acupuncture?
    Zhou Y; Garcia MK; Chang DZ; Chiang J; Lu J; Yi Q; Romaguera J; Delasalle K; Guo Y; Forman A; Fang W; Wang M
    Am J Clin Oncol; 2009 Jun; 32(3):319-25. PubMed ID: 19887992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin-associated neuropathy: a review.
    Cersosimo RJ
    Ann Pharmacother; 2005 Jan; 39(1):128-35. PubMed ID: 15590869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of peripheral neuropathy caused by microtubule inhibitors.
    Donovan D
    Clin J Oncol Nurs; 2009 Dec; 13(6):686-94. PubMed ID: 19948466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient perceptions associated with chemotherapy-induced peripheral neuropathy.
    Tofthagen C
    Clin J Oncol Nurs; 2010 Jun; 14(3):E22-8. PubMed ID: 20529785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of chemotherapy-induced peripheral neuropathy.
    Kaley TJ; Deangelis LM
    Br J Haematol; 2009 Apr; 145(1):3-14. PubMed ID: 19170681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
    Argyriou AA; Bruna J; Marmiroli P; Cavaletti G
    Crit Rev Oncol Hematol; 2012 Apr; 82(1):51-77. PubMed ID: 21908200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient guide to peripheral neuropathy.
    Almadrones LA; Arcot R
    Oncol Nurs Forum; 1999 Sep; 26(8):1359-60. PubMed ID: 10497775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity.
    Lanzani F; Mattavelli L; Frigeni B; Rossini F; Cammarota S; Petrò D; Jann S; Cavaletti G
    J Peripher Nerv Syst; 2008 Dec; 13(4):267-74. PubMed ID: 19192066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and management of peripheral neuropathy in diabetic patients with cancer.
    Visovsky C; Meyer RR; Roller J; Poppas M
    Clin J Oncol Nurs; 2008 Apr; 12(2):243-7. PubMed ID: 18390460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.